LaurentBrardMDPhD
Obstetrics & Gynecology • Springfield, ILGynecologic Oncology
Professor (with tenure) and Chief, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Southern Illinois University School of Medicine
Dr. Brard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
415 N 9th St
Ste 6w70
Springfield, IL 62702Phone+1 217-545-8882Fax+1 217-545-7958
Summary
- Dr. Laurent Brard is tenured professor of Obstetrics and Gynecology and chief of the Division of Gynecology Oncology in the Department of Obstetrics and Gynecology at the SIU School of Medicine in Springfield, IL and is affiliated with multiple hospitals in the area, including Springfield Memorial Hospital and HSHS St. John's Hospital. He received his medical degree from University of Pittsburgh School of Medicine and has been in practice 20 years. He also speaks multiple languages, including French. He specializes in gynecologic oncology and is experienced in gynecologic oncology and minimally invasive gynecologic surgery.
Education & Training
Women and Infants Hospital of Rhode Island/Brown UniversityFellowship, Gynecologic Oncology, 2002 - 2005- Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 1998 - 2002
University of Pittsburgh School of MedicineClass of 1998
Certifications & Licensure
IL State Medical License 2011 - 2026
RI State Medical License 1999 - 2020
MA State Medical License 2003 - 2018
CT State Medical License 2006 - 2017- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
- Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 230 citationsRural–Urban Differences in Cancer Incidence and Trends in the United StatesWhitney E. Zahnd, Aimee S. James, Wiley D. Jenkins, Sonya Izadi, Amanda Fogleman
Cancer Epidemiology, Biomarkers & Prevention. 2017-01-01 - 43 citationsAnti-angiogenic activity of cranberry proanthocyanidins and cytotoxic properties in ovarian cancer cellsKyu Kwang Kim, Ajay P. Singh, Rakesh K. Singh, Angelica M. DeMartino, Laurent Brard
International Journal of Oncology. 2011-09-12 - 58 citationsPhase II trial of erlotinib in women with squamous cell carcinoma of the vulvaNeil S. Horowitz, Alexander B. Olawaiye, Darrell R. Borger, Whitfield B. Growdon, Carolyn N. Krasner
Gynecologic Oncology. 2012-10-01
Professional Memberships
- Member
- Fellow
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
